BONE CANCER RESEARCH TRUST — grant history

Registered charity 1159590 · filings on the Charity Commission register · its own accounts analysis · funder finder · deadlines · watch this funder · check a grantee list

Latest income

£3.7m

Grants listed (FY2025)

Listed grants total

£3.1m

Accounts grants total

£3.5m

listed grants do not fully reconcile with the accounts total — list may be partialextracted from its FY2025 accounts

What this funder supports

Based on the register classifications and operating areas of the grant recipients we could match to the charity register (a subset of all grantees).

Causes funded

General Charitable Purposes (1 grantee)
Other Charitable Purposes (1 grantee)
The Advancement Of Health Or Saving Of Lives (1 grantee)

Where grantees operate

Northern Ireland (1 grantee)
Scotland (1 grantee)
Throughout England And Wales (1 grantee)

What changed: FY2024 → FY2025

Grantees that appear, disappear or move by 50%+ between the two most recent filings that have counted grants (unverified reads are left out, so a filing whose grants are all unverified is skipped). A grantee “dropped” may simply have received a multi-year grant earlier.

Change	Grantee	FY2024	FY2025
new	Professor Udo Oppermann, University of Oxford	—	£500k
new	Wenhui Song, University College London	—	£492k
new	Dr M McCabe, University of Manchester	—	£300k
new	Jonathan Fisher, UCL-Great Ormond Street Institute of Child Health	—	£250k
new	Clare Davies, University of Birmingham	—	£250k
new	Dr Sarah Snelling, University of Oxford	—	£250k
new	Lyratzopolous, University College London	—	£188k
new	External grant contributions	—	£134k
not listed	Dr Jun Ishihara, Imperial College London	£250k	—
not listed	Dr Martin Pule, University College London	£107k	—
not listed	Prof S Strauss, University College London	£68k	—
not listed	Jonathan Stevenson, Royal Orthapaedic Hospital	£55k	—
not listed	Prof Adrienne Flanagan, Royal National Orthapaedic Hospital	£50k	—
not listed	Dr Nezha Benabhallah, Edinburgh Cancer Research Centre	£35k	—
not listed	Dr Darrell Green	£28k	—
not listed	Dr Victoria Williamson, University of Oxford & University of Bath	£21k	—

Grants made, per its accounts filings

Download this grant history as CSV (open data, provenance and licence noted in the file).

Recipient	Year	Amount	Purpose
Professor Udo Oppermann, University of Oxford	FY2025	£500k	An integrated systems biology approach in chondrosarcoma to enable identification of pathogenic mechanisms and novel therapeutic targets
Wenhui Song, University College London	FY2025	£492k	Developing TCR-T immunotherapy for the treatment of Ewing Sarcoma
Dr M McCabe, University of Manchester	FY2025	£300k	The prognostic value of circulating tumour DNA and RNA and circulating IGF2BP3 protein in recurrent and refractory Ewing sarcoma: biomarker analysis from the rEECur trial
Jonathan Fisher, UCL-Great Ormond Street Institute of Child Health	FY2025	£250k	Exploring γδT cells for the treatment of Ewing Sarcoma in the lungs
Clare Davies, University of Birmingham	FY2025	£250k	Treating Ewing Sarcoma with PRMT5 inhibitors – a novel opportunity with real translational potential
Dr Sarah Snelling, University of Oxford	FY2025	£250k	SPEED: osteoSARCOMA Pathology Evaluation for Early Diagnosis
Lyratzopolous, University College London	FY2025	£188k	DIAGNOSED: Data-driven Integrated Approach to Generate Novel Opportunities for Sarcoma Early Diagnosis in primary care
External grant contributions	FY2025	£134k	External grant contributions
Professor Bernadette Brennan, Royal Manchester Children's Hospital	FY2025	£106k	Whole body diffusion-weighted imaging with background body signal suppression (WB-DWIBS) versus [18F]FDG PET/CT for the detection of skeletal metastases at diagnosis in Ewing sarcoma patients
Mr Kenneth Rankin, Newcastle University	FY2025	£99k	Optimisation of fluorescence technology for bone sarcoma image guided surgery and photodynamic therapy
Graham Cook , St. James’s University Hospital	FY2025	£87k	Oncolytic virus-based activation of natural killer cells for the immunotherapy of osteosarcoma
Mr Gareth Stephens, The Royal Orthopaedic Hospital, Birmingham	FY2025	£55k	Birmingham Infrastructure Y7
Dr Olivier Pardo, Imperial College London	FY2025	£44k	Targeting activation of fibroblasts to improve therapeutic response in osteosarcoma
Dr Casmir Turnquist, University of Oxford	FY2025	£35k	Long-read single cell RNA sequencing of mesenchymal chondrosarcoma (MCS)
Dr Mónica Pascual-García, Facultat de Biologia, Edifici Ramon Margalef	FY2025	£35k	Novel strategies to overcome immunosuppression in the tumour microenvironment
Dr Nikolas Herold, Karolinska Institutet K6 Kvinnors och barns hälsa	FY2025	£35k	Novel Combination Chemotherapy to Deplete Ewing Fusion Protein
Sanchez Molina, Fundació Sant Joan de Deu (FSJD), Institut de Recerca Sant Joan de Déu	FY2025	£35k	Epigenetic disruption of EWSR1-FLI1 condensates
Dr Olivier Pardo, Imperial College London	FY2025	£35k	Using vasculature-mimicking microfluidic systems to identify molecular changes associated with circulating osteosarcoma
Skills development grants	FY2025	£35k	Skills development grants
Dr Sam Au, Imperial College London	FY2025	£35k	Preclinical selection of STEAP1-targeting bispecific antibodies for Ewing Sarcoma using Microfluidic Avidity
Maximilian Knott, Division of Translational Paediatric Sarcoma Research (B410) German Cancer Research Center (DKFZ)	FY2025	£34k	Crossing the Line: Horizontal Fusion Oncoprotein Transfer as a Mechanism of Immunosuppression in Ewing Sarcoma
Professor Robin Plevin, University of Strathclyde	FY2025	£34k	Therapeutic targeting of IKKα in osteosarcoma using first-inclass selective IKKα inhibitors
Dr Lucia Cottone, UCL	FY2025	£4k	Cellular Dynamics Of Chemotherapy Resistance In Osteosarcoma (Missed extension Adjustment)
Dr Jun Ishihara, Imperial College London	FY2024	£250k	Overcoming osteosarcoma immunotherapy resistance by tumourlocalised IL-12 driven anti-tumour immunity.
Dr Martin Pule, University College London	FY2024	£107k	Years 2-4 of a PhD studentship - Towards Engineered T Cells for Osteosarcoma.
Mr Kenneth Rankin, Newcastle University	FY2024	£80k	Year 2 of the Surgical Consortium - Surgical consortium- Optimisation of fluorescence technology for bone sarcoma image guided surgery and photodynamic therapy.
Prof S Strauss, University College London	FY2024	£68k	Year 2 of the Euro Ewing Consortium.
Prof S Strauss, University College London	FY2024	£56k	Data Partnership Collaboration.
Jonathan Stevenson, Royal Orthapaedic Hospital	FY2024	£55k	Sample Collection Infrastructure Grant.
Prof Adrienne Flanagan, Royal National Orthapaedic Hospital	FY2024	£50k	Sample Collection Infrastructure Grant.
Dr Nezha Benabhallah, Edinburgh Cancer Research Centre	FY2024	£35k	Targeting Polycomb Assembly: A Novel Therapeutic Strategy for Bone Sarcoma Treatment.
Dr Darrell Green	FY2024	£28k	Single-cell profiling demonstrating childhood PBCintratumour heterogeneity: datasets for future reference
Jonathan Stevenson, Royal Orthapaedic Hospital	FY2024	£23k	Sample Collection Infrastructure Grant.
Dr Victoria Williamson, University of Oxford & University of Bath	FY2024	£21k	Full spectrum of primary bone tumours of the spine including benign and malignant spinal sarcoma.
Prof S Strauss	FY2024	£20k	Euro Ewing Consortium
Birmingham Orthopaedic Oncology Consensus Meeting (BOOM)	FY2024	£17k
Mr Kenneth Rankin, Newcastle University	FY2024	£16k	Sample Collection Infrastructure Grant.
Prof Aykut Uren, Georgetown University, Lombardi Comprehensive Cancer Centre	FY2024	£15k	Second Generation Clofarabine Derivatives as CD99 Inhibitors
Dr Abigail Evans, UCL	FY2024	£12k	Meeting support EEC 2023
Grant salary and consumables final claim June 2023 from KING001	FY2024	£10k
Dr N Gaspar, Gustave Roussy	FY2024	£9k	Meeting Grant Award to support The FOSTER annual meeting.
Graham Cook, The University of Leeds	FY2024	£6k	Oncolytic virus therapy for Ewing’s sarcoma
Prof Agamemnon Grigoriadis, King’s College London	FY2024	£6k	Haem oxygenase-1 (HO-1), a novel druggable target for prevention of osteosarcoma growth and metastasis
Research Grants Awarded	FY2024	£3k
Dr Katherine Trevers	FY2024	£600
Dr P Huang, Institute of Cancer Research, A deep dive into the proteomic landscape of chondrosarcoma: improving patient stratification and outcomes	FY2023	£250k	Research
Professor Alison Gartland, University of Sheffield, Understanding Chondrosarcoma from pathogenesis to new treatment options	FY2023	£162k	Research
Prof Sybille Mittnacht, UCL, Cancer Institute, PhD studentship	FY2023	£119k	Research
Prof Judith Bovee, Leiden University, Unravelling adamantinoma histogenesis	FY2023	£100k	Research
Prof S Strauss, UCL, Euro Ewing Consortium	FY2023	£99k	Research
Mr Kenneth Rankin, Newcastle, Optimisation of fluorescence technology for bone sarcoma image guided surgery and photodynamic therapy	FY2023	£77k	Research
Dr P Huang, Institute of Cancer Research, Evaluation of a gene expression-based risk classifier for tyrosine kinase inhibitor therapy in the INTER-EWING-1 and rEECur trials.	FY2023	£50k	Research
Stanmore infrastructure	FY2023	£42k	Research
Prof Sally Fletcher, University of Birmingham, Leveraging a new class of drug target to develop novel combination therapies for Chondrosarcoma	FY2023	£25k	Research
Dr M McCabe - Biological studies in rEECur, an international randomised controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma	FY2023	£23k	Research
Dr Katherine Trevers, UCL, Can cell-free RNA (cfRNA) be used to measure disease burden in chordoma	FY2023	£23k	Research
Dr Darrell Green, University of East Anglia, Single-cell profiling demonstrating childhood PBCintratumour heterogeneity: datasets for future reference	FY2023	£17k	Research
Skills development grants	FY2023	£15k	Research
Birmingham Orthopaedic Oncology Consensus Meeting (BOOM)	FY2023	£12k	Research
Prof Aykut Uren, Georgetown University, Lombardi Comprehensive Cancer Centre, Second Generation Clofarabine Derivatives as CD99 Inhibitors	FY2023	£3k	Research
Dr Abigail Evans, UCL, Meeting support EEC 2023	FY2023	£600	Research
Professor Sandra Strauss	FY2022	£998k	Ad-ICONIC Programme
Dr Lucia Cottone	FY2022	£500k	Cellular Dynamics Of Chemotherapy Resistance In Osteosarcoma Early Career Fellowship
Dr Paul Huang	FY2022	£250k	A deep dive into the proteomic landscape of chondrosarcoma: improving patient stratification and outcomes Large Project
Professor Alison Gartland	FY2022	£250k	Preclinical validation of novel compounds to treat osteosarcoma Large Project
Professor Robert Falconer	FY2022	£250k	Lead optimisation of a tumour-targeted methotrexate prodrug with enhanced therapeutic index for osteosarcoma Large Project
Dr Martin McCabe	FY2022	£188k	Biological studies in rEECur, an international randomised controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma Clinical Trial Support
Mr Gareth Stevens	FY2022	£54k	Sample Collection Support Grant - Birmingham (Y5) Infrastructure
Dr Hadley Sheppard	FY2022	£25k	Evaluating the therapeutic potential of senolytic agents in chordoma Idea
Professor Richard Martin	FY2022	£25k	Developing novel biomaterials for osteosarcoma and chordoma treatment Idea
Dr Katherine Trevers	FY2022	£23k	A proof of concept study: can cell-free RNA (cfRNA) be used to measure disease burden in chordoma? Ideas
Mr Kenneth Rankin	FY2022	£16k	Sample Collection Support Grant - Newcastle (Y5) Infrastructure
Dr Helen Knowles	FY2022	£10k	ANGPTL4 is a potential therapeutic target in osteosarcoma Idea
Dr Kogularamanan Suntharalingam	FY2022	£10k	Bone-seeking Metal-based Drugs to overcome Chemotherapy Resistant Osteosarcoma Subpopulations Idea
Mr Corey Chan	FY2022	£3k	Lab stay at Harvard Medical School Skills Development Grant
Dr Darrell Green	FY2022	£2k	TP53 Restoration using mRNA Vaccine Technology Idea
Dr Martin Pule	FY2022	£2k	Towards Engineered T Cells for Osteosarcoma PhD Studentship
Mr Fermin Pradies-Pinchete	FY2022	£1k	Lab stay at University of East Anglia Skills Development Grant
Miss Laura Regadera-Munoz	FY2022	£1k	Lab stay at University of East Anglia Skills Development Grant
Dr Stefan Zollner	FY2022	£723	Travel grant for Advances in Ewing Sarcoma meeting Skills Development Grant
Dr Joanna Kitlinska	FY2022	£500	Travel grant for Advances in Ewing Sarcoma meeting Skills Development Grant
Dr Sara Sanchez Molina	FY2022	£500	Travel grant for Advances in Ewing Sarcoma meeting Skills Development Grant
Dr Maria Christina Manara	FY2022	£500	Travel grant for Advances in Ewing Sarcoma meeting Skills Development Grant
Mr Maximilian Kerkoff	FY2022	£392	Travel grant for Advances in Ewing Sarcoma meeting Skills Development Grant
Mrs Sarah Vaughan	FY2022	£390	Travel grant for BSG attendance Skills Development Grant
Dr Antonio Romo Morales	FY2022	£235	Travel grant for Advances in Ewing Sarcoma meeting Skills Development Grant
Mr Tilman Hoelting	FY2022	£219	Travel grant for Advances in Ewing Sarcoma meeting Skills Development Grant
Ms Silvia Luchetta	FY2022	£200	Travel grant for Advances in Ewing Sarcoma meeting Skills Development Grant
Ms Sophie Richardson	FY2022	£57	Travel grant for Advances in Ewing Sarcoma meeting Skills Development Grant
Dr Olivier Pardo	FY2021	£250k	Modulation of interferon gamma-mediated signalling and immune response by fibroblast growth factor 2 in osteosarcoma
Professor Sibylle Mittnacht	FY2021	£249k	Developing genome-informed treatment to improve outcome in Osteosarcoma
Dr Sandra Strauss	FY2021	£175k	ICONIC: Improving outcome through Collaboration in OsteosarComa (Stage 2)
Professor Susan Burchill	FY2021	£150k	International collaboration to optimise the management of patients with Ewing sarcoma
Professor Gareth Veal	FY2021	£146k	Optimising the Treatment of Teenagers and Young Adults with Ewing Sarcoma through an Increased Understanding of Clinical Pharmacology and Toxicity Biomarkers
Professor Aykut Uren	FY2021	£70k	2nd Generation Clofarabine derivatives as CD99 inhibitors
Sarcoma UK	FY2021	£43k	Improving outcome in Sarcoma through Analysis and interrogation of National Cancer Data
University College London	FY2021	£36k	Euro Ewing Consortium
Dr Martin Pule	FY2021	£35k	Towards Engineered T Cells for Osteosarcoma (Year 1 Award)
Mr Jonathan Stevenson	FY2021	£30k	Sample Collection Support Grant - Birmingham (Y4)
Professor Adrienne Flanagan	FY2021	£28k	Sample Collection Support Grant - Stanmore (Y4)
Dr Darrell Green	FY2021	£20k	TP53 restoration using mRNA vaccine technology
Dr Kogularamanan Suntharalingam	FY2021	£20k	Bone-seeking metal-based drugs to overcome chemotherapy-resistant osteosarcoma subpopulations
Dr Karan Shah	FY2021	£20k	Delineating the role of hypoxic extracellular vesicles in pulmonary metastasis of osteosarcoma – a pilot study
Professor Alison Gartland	FY2021	£17k	The Role of Oestrogen in Chondrosarcoma Using Patient-Derived Xenograft Mouse Models: A Pilot study
Professor Robert Falconer	FY2021	£17k	Development of a targeted methotrexate prodrug with enhanced therapeutic index for osteosarcoma
Mr Kenneth Rankin	FY2021	£16k	Sample Collection Support Grant - Newcastle (Y4)

About this data

This grant list is extracted by automated reading of the grant-maker’s own accounts PDFs as filed with the Charity Commission, and cross-checked against the accounts’ stated grant totals (listed sum 3070794 vs reference 3537384 (13.2% diff; ref=stated)). Recipients are linked to register entries only on an exact charity-number or unambiguous exact-name match. If you represent this funder or a recipient and want a correction, email [email protected].